Efficacy and Safety of Anlotinib Combined with PD-1 Blockades for Patients with Advanced Epithelial Ovarian Cancer

Efficacy and Safety of Anlotinib Combined with PD-1 Blockades for Patients with Advanced Epithelial Ovarian Cancer

Objective To investigate the efficacy and safety of anlotinib combined with PD-1 blockades for patients with advanced epithelial ovarian cancer (EOC). Methods A retrospective study was performed, enrolling 33 patients with advanced EOC who failed standard systematic therapy. All patients were admini...

Full description

Bibliographic Details
Main Authors: JIN Huimin, LIN Lihong, ZHAO Zhen, GONG Xishuang
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2022-10-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
epithelial ovarian cancer
anlotinib
pd-1 blockade
efficacy
adverse effect
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0211

Similar Items

Similar Items